Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four versus six weeks of antibiotics for complicated Staphylococcus aureus bacteremia
NL-OMON54379Phase 4Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Sep 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Staphylococcal bacteremia and Staphylococcus aureus bloodstream infection (SABSI) (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Success of therapy at 180 days after randomization. Started Sep 2020; status: recruiting.
02
Conditions
Staphylococcal bacteremiaStaphylococcus aureus bloodstream infection (SABSI)
Beyond the preview
Go deeper on NL-OMON54379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54379.